Remote monitoring (RM) of cardiac implantable electronic devices has become established as a standard of care over the past decade. This system enables early detection of arrhythmic events and optimizes follow-up of patients with implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy with defibrillator (CRT-D). However, debate persists regarding its impact on "hard" clinical outcomes, particularly mortality.
In this context, the study by Guzmán et al., published in the Argentine Journal of Cardiology (RAC), provides relevant real-world evidence by analyzing the prognostic value of ventricular arrhythmia alerts detected through RM in a cohort of patients with ICD and CRT-D. (1) The authors demonstrated that alerts for non-sustained ventricular tachycardia, ventricular tachycardia, or ventricular fibrillation were significantly associated with increased all-cause mortality, with an early and sustained separation of the survival curves. This finding reinforces the concept that remote monitoring provides clinically relevant information, beyond the mere detection of events, reflecting the progression of the underlying heart disease.
A notable aspect of the study is its observational nature and its conduct in a routine clinical practice setting, which allows it to reflect a heterogeneous and complex population, that differs from those typically included in randomized clinical trials. In this regard, the results are consistent with large observational registries, such as the ALTITUDE study, which identified ventricular arrhythmias and defibrillator therapies as adverse prognostic markers. (2) Similarly, previous studies have shown that the occurrence of appropriate shocks is associated with a significant increase in mortality, regardless of the underlying etiology of heart disease. (3)
However, the study also highlights a relevant clinical limitation: in most cases, the detection of ventricular alerts did not lead to substantial changes in therapeutic management. This finding raises a key question for daily practice: is early identification of high-risk patients sufficient if this information is not integrated into a structured intervention strategy?
The true value of RM may lie not only in the generation of alerts, but also in their interpretation within the patient's overall clinical context. Ventricular arrhythmias should act as a trigger for a comprehensive reassessment, including optimization of heart failure therapy, review of device programming, and consideration of advanced strategies such as catheter ablation or multidisciplinary management. (4)
In conclusion, the study by Guzmán et al. reinforces the role of ventricular alerts detected through RM as prognostic markers in patients with ICD and CRT-D. The future challenge is to translate this information into concrete clinical decisions that not only improve risk stratification but also modify the natural history of the disease, in line with current international consensus recommendations. (5)